Cardiology Department Lille Catholic Hospitals Heart Valve Center Lille Catholic University Lille France.
Centre Hospitalier Universitaire d'Amiens Amiens France.
J Am Heart Assoc. 2021 Dec 7;10(23):e021873. doi: 10.1161/JAHA.121.021873. Epub 2021 Nov 30.
Background The ratio of acceleration time/ejection time (AT/ET) is a simple and reproducible echocardiographic parameter that integrates aortic stenosis severity and its consequences on the left ventricle. No study has specifically assessed the prognostic impact of AT/ET on outcome in patients with high-gradient severe aortic stenosis (SAS) and no or mild symptoms. We sought to evaluate the relationship between AT/ET and mortality and determine the best predictive AT/ET cutoff value in these patients. Methods and Results A total of 353 patients (median age, 79 years; 46% women) with high-gradient (mean pressure gradient ≥40 mm Hg and/or aortic peak jet velocity ≥4 m/s) SAS, left ventricular ejection fraction ≥50%, and no or mild symptoms were studied. The impact of AT/ET ≤0.35 or >0.35 on all-cause mortality was retrospectively studied. During a median follow-up of 39 (25th-75th percentile, 23-62) months, 70 patients died. AT/ET >0.35 was associated with a considerable increased mortality risk after adjustment for established prognostic factors in SAS under medical and/or surgical management (adjusted hazard ratio [HR], 2.54; 95% CI, 1.47-4.37; <0.001) or conservative management (adjusted HR, 3.29; 95% CI, 1.70-6.39; <0.001). Moreover, AT/ET >0.35 improved the predictive performance of models including established risk factors in SAS with better global model fit, reclassification, and discrimination. After propensity matching, increased mortality risk persisted when AT/ET >0.35 (adjusted HR, 2.10; 95% CI, 1.12-3.90; <0.001). Conclusions AT/ET >0.35 is a strong predictor of outcome in patients with SAS and no or only mild symptoms and identifies a subgroup of patients at higher risk of death who may derive benefit from earlier aortic valve replacement.
加速时间/射血时间(AT/ET)比值是一种简单且可重复的超声心动图参数,可综合评估主动脉瓣狭窄严重程度及其对左心室的影响。尚无研究专门评估在无或仅有轻度症状的高梯度重度主动脉瓣狭窄(SAS)患者中,AT/ET 对结局的预测作用。我们旨在评估 AT/ET 与死亡率之间的关系,并确定这些患者中最佳的预测 AT/ET 截断值。
共纳入 353 例(中位年龄 79 岁,46%为女性)高梯度(平均压力梯度≥40mmHg 和/或主动脉峰值射流速度≥4m/s)SAS、左心室射血分数≥50%且无或仅有轻度症状的患者。回顾性研究 AT/ET≤0.35 或>0.35 对全因死亡率的影响。中位随访 39(25 至 75 百分位数,23 至 62)个月期间,70 例患者死亡。校正 SAS 下医学和/或手术管理(校正后危险比 [HR],2.54;95%置信区间 [CI],1.47-4.37;<0.001)或保守治疗(校正 HR,3.29;95% CI,1.70-6.39;<0.001)中既定预后因素后,AT/ET>0.35 与死亡率显著增加相关。此外,与包括 SAS 中既定危险因素在内的模型相比,AT/ET>0.35 可改善模型的整体拟合度、重新分类和区分能力,从而提高预测效果。经过倾向匹配后,当 AT/ET>0.35 时,死亡率增加的风险仍然存在(校正 HR,2.10;95% CI,1.12-3.90;<0.001)。
在无或仅有轻度症状的 SAS 患者中,AT/ET>0.35 是结局的有力预测指标,可识别出死亡率较高的亚组患者,这些患者可能从早期主动脉瓣置换中获益。